Researchers successfully use Parsortix system in ovarian cancer drug trials
ANGLE plc's Parsortix, which was granted a European patent in March 2016, harvests circulating cancer cells from blood for further medical analysis. Its use is an essential step in research under the GANNET53 project, which ...
Aug 18, 2016
0
2